organophosphonates has been researched along with Eye Infections, Viral in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 4 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hawley, J; Lappin, M; Powell, C; Rekers, W; Veir, J; Zirofsky, D | 1 |
| Auw-Haedrich, C; Graef, S; Kern, WV; Kurth, A; Nitsche, A; Plange, N; Reinhard, T | 1 |
| Feucht, N; Hadeler, J; Lanzl, I; Loos, D; Schmid, RM; Schwerdtfeger, C; Spinner, CD | 1 |
| Barshak, MB; Durand, ML; Foster, CS; Kim, IK; Mali, JO; Scott, NL; Stryjewski, TP; Tobin, EH; Young, LH | 1 |
| de Groot-Mijnes, JD; Rothova, A; Schneider, M | 1 |
| Bolger, GT; Bousquet, C; Cordingley, MG; Garneau, M; Kibler, P; Tremblay, F | 1 |
| Abe, M; Aoki, K; Iida, T; Kaneko, H; Mori, S; Ohno, S; Shigeta, S; Suzuki, O; Suzutani, T | 1 |
| Aldern, K; Beadle, JR; Bessho, K; Bovet, JM; Cheng, L; Freeman, WR; Hostetler, KY; Koh, HJ; Lee, J; Toyoguchi, M | 1 |
| Gordon, YJ; Irschick, EU; Nagl, M; Romanowski, EG; Teuchner, B; Yates, KA | 1 |
| Gambotto, A; Gordon, YJ; Nwanegbo, EC; Romanowski, EG | 1 |
| Assil, KK; Bergeron-Lynn, G; Besen, G; De Clercq, E; Flores-Aguilar, M; Gangan, P; Kupperman, BD; Munguia, D; Pursley, M; Vuong, C | 1 |
| Araullo-Cruz, T; Gordon, YJ; Romanowski, EG | 1 |
| Assil, KK; Bergeron-Lynn, G; Besen, G; Connor, JD; De Clercq, E; Freeman, WR; Kuppermann, BD; Munguia, D; Pursley, M; Vuong, C; Wiley, CA | 1 |
| Gordon, YJ; Romanowski, EG | 2 |
| Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R | 2 |
| Chakrabarti, S; Collingham, KE; Fegan, CD; Milligan, DW; Osman, H | 1 |
| Araullo-Cruz, T; De Clercq, E; Gordon, YJ; Romanowski, E | 1 |
2 trial(s) available for organophosphonates and Eye Infections, Viral
| Article | Year |
|---|---|
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Treatment Outcome | 2001 |
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.
Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Conjunctiva; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Eyelids; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Safety | 2002 |
18 other study(ies) available for organophosphonates and Eye Infections, Viral
| Article | Year |
|---|---|
Feline Herpesvirus 1 and Mycoplasma spp. Conventional PCR Assay Results From Conjunctival Samples From Cats in Shelters With Suspected Acute Ocular Infections.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Antiviral Agents; Cat Diseases; Cats; Cidofovir; Conjunctiva; Cytosine; DNA, Bacterial; DNA, Viral; Eye Infections, Bacterial; Eye Infections, Viral; Herpesviridae Infections; Mycoplasma; Mycoplasma Infections; Ointments; Ophthalmic Solutions; Organophosphonates; Oxytetracycline; Polymerase Chain Reaction; Varicellovirus | 2018 |
Clinicopathological findings in persistent corneal cowpox infection.
Topics: Antiviral Agents; Cidofovir; Combined Modality Therapy; Corneal Ulcer; Cowpox; Cowpox virus; Cytosine; DNA, Viral; Eye Infections, Viral; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Middle Aged; Mycophenolic Acid; Organophosphonates; Real-Time Polymerase Chain Reaction; Reoperation; Virus Activation; Visual Acuity | 2013 |
[Ophthalmological alterations at the initial diagnosis of HIV infection].
Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Cyclohexanes; Deoxycytidine; Drug Therapy, Combination; Early Diagnosis; Emtricitabine; Eye Infections, Viral; HIV Infections; Humans; Lopinavir; Male; Maraviroc; Organophosphonates; Retinal Diseases; Syndrome; Tenofovir; Treatment Outcome; Triazoles; Zidovudine | 2014 |
Treatment of Refractory Acute Retinal Necrosis with Intravenous Foscarnet or Cidofovir.
Topics: Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Foscarnet; Herpes Simplex; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Infusions, Intravenous; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; Vitreous Body | 2018 |
Human immunodeficiency virus-induced uveitis: intraocular and plasma human immunodeficiency virus-1 RNA loads.
Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Aqueous Humor; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Eye Infections, Viral; HIV Antibodies; HIV Infections; HIV-1; Humans; Male; Organophosphonates; Polymerase Chain Reaction; RNA, Viral; Tenofovir; Uveitis, Anterior; Viral Load | 2008 |
HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique.
Topics: Animals; Antiviral Agents; Cidofovir; Cytomegalovirus Retinitis; Cytosine; Disease Models, Animal; Electroretinography; Eye Infections, Viral; Female; Herpesviridae Infections; Humans; Mice; Mice, SCID; Muromegalovirus; Organophosphonates; Organophosphorus Compounds; Retina; Treatment Outcome; Virus Replication | 2003 |
The cotton rat model for adenovirus ocular infection: antiviral activity of cidofovir.
Topics: Adenoviridae Infections; Adenoviruses, Human; Administration, Topical; Animals; Antigens, Viral; Antiviral Agents; Cidofovir; Conjunctivitis, Viral; Cornea; Cytosine; Disease Models, Animal; Drug Evaluation, Preclinical; Eye Infections, Viral; Female; Organophosphonates; Organophosphorus Compounds; Rats; Sigmodontinae; Viral Plaque Assay; Virus Replication; Virus Shedding | 2004 |
Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Topics: Animals; Antiviral Agents; Area Under Curve; Biological Availability; Chromatography, High Pressure Liquid; Cytosine; Drug Delivery Systems; Eye Infections, Viral; Ganciclovir; Herpes Simplex; Herpesvirus 1, Human; Liposomes; Microfluidics; Organophosphonates; Prodrugs; Rabbits; Retina; Retinitis; Vitreous Body | 2004 |
N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Cornea; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Eye Infections, Viral; Female; Keratitis; Ophthalmic Solutions; Organophosphonates; Rabbits; Taurine; Viral Plaque Assay; Virus Replication | 2006 |
Efficacy of topical immunoglobulins against experimental adenoviral ocular infection.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cell Culture Techniques; Cidofovir; Conjunctiva; Cornea; Cytosine; Disease Models, Animal; Epithelial Cells; Eye Infections, Viral; Flow Cytometry; Immunoglobulins, Intravenous; Immunologic Factors; Keratoconjunctivitis; Organophosphonates; Rabbits; Treatment Outcome; Virus Cultivation; Virus Replication; Virus Shedding | 2007 |
Long-term therapy for herpes retinitis in an animal model with high-concentrated liposome-encapsulated HPMPC.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Electroretinography; Eye Infections, Viral; Fundus Oculi; Herpes Simplex; Liposomes; Longitudinal Studies; Organophosphonates; Organophosphorus Compounds; Rabbits; Retinitis | 1995 |
Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model.
Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Female; Humans; Keratoconjunctivitis; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Rabbits; Virus Replication; Virus Shedding | 1994 |
Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.
Topics: Animals; Antiviral Agents; Cidofovir; Cytosine; Disease Models, Animal; Drug Carriers; Eye Infections, Viral; Herpes Simplex; Herpesvirus 1, Human; Injections; Liposomes; Organophosphonates; Organophosphorus Compounds; Rabbits; Retina; Retinitis; Vitreous Body | 1996 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases | 1997 |
Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Female; Keratoconjunctivitis; Organophosphonates; Organophosphorus Compounds; Rabbits; Viral Plaque Assay; Virus Cultivation; Virus Replication; Virus Shedding | 2000 |
Effects of diclofenac or ketorolac on the inhibitory activity of cidofovir in the Ad5/NZW rabbit model.
Topics: Adenovirus Infections, Human; Adenoviruses, Human; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cidofovir; Corneal Stroma; Cytosine; Diclofenac; Drug Interactions; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Keratitis; Ketorolac Tromethamine; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Rabbits; Random Allocation; Virus Replication; Virus Shedding | 2001 |
Cidofovir as primary pre-emptive therapy for post-transplant cytomegalovirus infections.
Topics: Adult; Antiviral Agents; Cidofovir; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; DNA, Viral; Drug Evaluation; Eye Infections, Viral; Female; Foscarnet; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Probenecid; Recurrence; Safety; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Uveitis, Anterior; Viral Load; Viremia; Vomiting | 2001 |
Pretreatment with topical 0.1% (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine inhibits adenovirus type 5 replication in the New Zealand rabbit ocular model.
Topics: Adenoviridae; Adenoviridae Infections; Animals; Antiviral Agents; Cidofovir; Colony Count, Microbial; Corneal Diseases; Corneal Stroma; Cytosine; Disease Models, Animal; Eye Infections, Viral; Female; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Premedication; Rabbits; Virus Replication | 1992 |